|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.860 USD | -0.26% |
|
-13.65% | +14.54% |
| 07-14 | Ironwood Pharmaceuticals, Inc. Announces Management Changes | CI |
| 05-27 | Ironwood Says US FDA Approves Linzess Use in Children Aged Two Years and Older With Functional Constipation | MT |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Neutral | Bullish |
| Resistance | 4.77 | 5.39 | 5.23 |
| Spread/Res. | -19.08% | -28.39% | -26.20% |
| Spread/Supp. | +26.97% | +26.97% | +57.05% |
| Support | 3.04 | 3.04 | 2.458 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- IRWD Stock
- Charts Ironwood Pharmaceuticals, Inc.
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
